Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The consumption of antibiotics has increased significantly over the past 15 years, according to a recent study. The increase occurred despite the international push to reduce the use of these important drugs.

Researchers found that while many low- and middle-income countries still lack appropriate access to antibiotics, the global increase was driven largely by some developing countries which face more drug-resistant infections and a lack of tools to test infections and track how these medications are used.

To tackle antimicrobial resistance (AMR), we need to look at all the factors behind how and when antibiotics are used. One obstacle I often see as a medical microbiologist working in developing countries, is a lack of access to clean water, which makes preventing and controlling infections nearly impossible. It is a major driver of inappropriate antibiotic use and, ultimately, the growth in antibiotic-resistant bugs – so-called “superbugs”.

Read the full article on The Conversation website, written by Abhilasha Karkey (Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine). 

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Ancient gene mutation found to cause rare hereditary condition

General Research

UK scientists have found that a 7,000-year-old genetic mutation is responsible for a rare form of hereditary motor neuropathy (HMN).

National consortium to study threats of new SARS-CoV-2 variants

Coronavirus COVID-19 General Research

A new national research project to study the effects of emerging mutations in SARS-CoV-2 will be launched with £2.5 million funding from UK Research and Innovation (UKRI).

Immunology preprint reviews launched in Nature Reviews Immunology

General Research

The Oxford-Mount Sinai (OxMS) Preprint Journal Club has partnered with Nature Reviews Immunology to launch a monthly Preprint Watch column.

No limit to the benefits of exercise in reducing the risk of cardiovascular disease

General Research

A new study led by the University of Oxford on over 90,000 participants shows that there is no upper threshold to the benefits of exercise in reducing the risk of cardiovascular disease – ‘every move counts towards better cardiovascular health.’

Accurate predictions of ovarian cancer outcome possible with new classification system

General Research

The new, Oxford-developed method for subtyping ovarian cancer has been validated in a recent collaboration between the University of Oxford and Imperial College London. Dubbed the ‘Oxford Classic’, researchers have demonstrated that it enables the accurate prediction of patient disease outcome, as well as the development of new targeted cancer therapies.